MAPT and Alzheimer disease: Alzheimer’s Disease (AD) is characterized by abundant amyloid-β (Aβ) plaques, neurofibrillary tau tangles, mitochondria dysfunction, disrupted synaptic signaling, and loss of synapses, all of which contribute to neuronal degeneration and loss.